dpp4 and glp 1 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner The pharmacology of DPP-4 inhibitors

Moringa leaves have shown a laxative effect, making moringa a possible option for constipation

Regular use may contribute to a more supported skin feel, promoting a look of enhanced elasticity and firmness

Novo Nordisk effectively created the modern obesity drug market with the launch of WEGOVY (semaglutide) in 2021, transforming obesity management from a lifestyle-focused intervention into a highly effective pharmacological treatment option

Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease

It is important to emphasize that there is currently no FDA-approved indication for GLP-1 receptor agonists in the treatment of alcohol use disorder (AUD)

Vitamin C helps regenerate and prolong glutathione effects